Apollo Hospitals Q3 results: Profit rises 35% YoY to Rs 502 crore; Rs 10 per share dividend declared

Leading hospital chain Apollo Hospitals reported 35% year-on-year (year-on-year) growth in consolidated net profit at Rs 502 crore in the third quarter. The Board of Directors has also declared an interim dividend of Rs 10 per share for the financial year 2026.The registration date for this has been set for February 16th and payment will be made on or before February 27th.

Revenue for the third quarter stood at Rs 6,477 crore, against Rs 5,527 crore in the same quarter last year, showing a growth of 17%.EBITDA, meanwhile, rose to Rs 965 crore in the reporting quarter, compared to Rs 762 crore in Q3FY25. This is after Apollo 24/7 cost of Rs 124 crore in the quarter.

Its healthcare business posted revenues of Rs 3,183 crore in Q3FY26, compared to Rs 2,785 crore in the same quarter last year, registering 14% year-on-year growth. EBITDA for the segment rose 18% to Rs 790 crore, while margins improved to 24.8%.

The company’s profit after tax stood at Rs 422 crore, up 21% from Rs 348 crore a year earlier, supported by higher occupancy rates, better case mix and cost efficiency.

Apollo Health and Lifestyle, which houses the company’s clinics, diagnostics and childcare formulas, also reported healthy growth. Segment revenue rose 20% year-on-year to Rs 467 crore in Q3FY26, compared to Rs 390 crore in the corresponding quarter last year. EBITDA rose 39% from Rs 34 crore to Rs 48 crore, with margins increasing to 10.2%. The segment reported a net loss of Rs 6 crore during the quarter, which was smaller than a loss of Rs 8 crore in Q3FY25, due to improved scale and operating leverage.

Apollo HealthCo, which includes the company’s pharmacy distribution, digital health and consumer health platforms, delivered a sharp improvement in profitability. Revenue rose 20% year-on-year to Rs 2,827 crore in Q3FY26. EBITDA more than doubled to Rs 128 crore from Rs 57 crore in Q3FY25, with margins improving to 4.5%. Profit after tax for the segment rose to Rs 87 crore, compared to Rs 32 crore in the same quarter last year.

“This quarter, continued investments in advanced clinical capabilities translated into meaningful advances in key specialties, from Apollo OMR completing 150 robotic joint replacement surgeries in its first 150 days, to expanding our stroke care network in Chennai with nine advanced stroke laboratories, strengthening rapid access to care and outcomes,” said Dr. Prathap C Reddy, Chairman, Apollo Hospitals.

Apollo said it will work closely with policymakers and state partners to strengthen international patient pathways, expand high-acuity capacity and ensure seamless coordination between pre-travel assessment, clinical care and post-discharge follow-up.